Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 3 |
2021 | 2 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
New Insights into the Role of Sphingolipid Metabolism in Melanoma.
Cells. 2020 Aug 26;9(9):1967. doi: 10.3390/cells9091967.
Cells. 2020.
PMID: 32858889
Free PMC article.
Review.
Lipid metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives.
Pellerin L, Carrié L, Dufau C, Nieto L, Ségui B, Levade T, Riond J, Andrieu-Abadie N.
Pellerin L, et al. Among authors: dufau c.
Cancers (Basel). 2020 Oct 27;12(11):3147. doi: 10.3390/cancers12113147.
Cancers (Basel). 2020.
PMID: 33121001
Free PMC article.
Review.
Item in Clipboard
Anti-TNF, a magic bullet in cancer immunotherapy?
Montfort A, Dufau C, Colacios C, Andrieu-Abadie N, Levade T, Filleron T, Delord JP, Ayyoub M, Meyer N, Ségui B.
Montfort A, et al. Among authors: dufau c.
J Immunother Cancer. 2019 Nov 14;7(1):303. doi: 10.1186/s40425-019-0802-y.
J Immunother Cancer. 2019.
PMID: 31727152
Free PMC article.
Item in Clipboard
A fluorogenic substrate for the detection of lipid amidases in intact cells.
Casasampere M, Ung J, Iñáñez A, Dufau C, Tsuboi K, Casas J, Tan SF, Feith DJ, Andrieu-Abadie N, Segui B, Loughran TP Jr, Abad JL, Fabrias G.
Casasampere M, et al. Among authors: dufau c.
J Lipid Res. 2024 Mar;65(3):100520. doi: 10.1016/j.jlr.2024.100520. Epub 2024 Feb 17.
J Lipid Res. 2024.
PMID: 38369184
Free PMC article.
Item in Clipboard
Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti-PD-1 Therapy Efficacy.
Montfort A, Bertrand F, Rochotte J, Gilhodes J, Filleron T, Milhès J, Dufau C, Imbert C, Riond J, Tosolini M, Clarke CJ, Dufour F, Constantinescu AA, Junior NF, Garcia V, Record M, Cordelier P, Brousset P, Rochaix P, Silvente-Poirot S, Therville N, Andrieu-Abadie N, Levade T, Hannun YA, Benoist H, Meyer N, Micheau O, Colacios C, Ségui B.
Montfort A, et al. Among authors: dufau c.
Cancer Immunol Res. 2021 May;9(5):568-582. doi: 10.1158/2326-6066.CIR-20-0342. Epub 2021 Mar 16.
Cancer Immunol Res. 2021.
PMID: 33727246
Free PMC article.
Item in Clipboard
Combining Nivolumab and Ipilimumab with Infliximab or Certolizumab in Patients with Advanced Melanoma: First Results of a Phase Ib Clinical Trial.
Montfort A, Filleron T, Virazels M, Dufau C, Milhès J, Pagès C, Olivier P, Ayyoub M, Mounier M, Lusque A, Brayer S, Delord JP, Andrieu-Abadie N, Levade T, Colacios C, Ségui B, Meyer N.
Montfort A, et al. Among authors: dufau c.
Clin Cancer Res. 2021 Feb 15;27(4):1037-1047. doi: 10.1158/1078-0432.CCR-20-3449. Epub 2020 Dec 3.
Clin Cancer Res. 2021.
PMID: 33272982
Clinical Trial.
Item in Clipboard
Cite
Cite